Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 01-2022 | 10-2021 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | N/A | 137 |
| Marketable Securities | N/A | 205 |
| Receivables | N/A | 104 |
| Other current assets | 0 | 15 |
| TOTAL | $N/A | $461 |
| Non-Current Assets | ||
| PPE Net | N/A | 14 |
| TOTAL | $N/A | $14 |
| Total Assets | $N/A | $876 |
| Liabilities | ||
| Current Liabilities | ||
| TOTAL | $N/A | $2,049 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $N/A | $2,049 |
| Shareholders' Equity | ||
| Shares Outstanding, K | N/A | 82 |
| Retained earnings | N/A | -10,759 |
| Other shareholders' equity | 0 | 9,586 |
| TOTAL | $N/A | $-1,173 |
| Total Liabilities And Equity | $0 | $876 |